Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia : a prospective cross-sectional study

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..

INTRODUCTION: Epidemiological data about diabetes mellitus (DM) for sub-Saharan Africa (SSA) are scarce and the utility of glycated hemoglobin (HbA1c) to diagnose DM is uncertain in African populations with a high proportion of anemia.

RESEARCH DESIGN AND METHODS: In a cross-sectional study, age-adjusted prevalence rates and predictors for DM and pre-DM were prospectively assessed by HbA1c in a semirural walk-in population of Tanzania (n=992). Predictors for DM were calculated by logistic regression. Correlations between HbA1c, hemoglobin, and blood glucose levels were done by Pearson's correlation.

RESULTS: Overall, DM and pre-DM prevalence rates were 6.8% (95% CI 5.3 to 8.5) and 25% (95% CI 22.8 to 28.3), respectively. There was an increase in DM prevalence in patients 50-59 (14.9%; 95% CI 9.1 to 22.5), ≥60 years old (18.5%; 95% CI 12.2 to 26.2) and in patients with overweight (9.3%; 95% CI 5.9 to 13.7), obesity (10.9%; 95% CI 6.9 to 16) compared with patients 18-29 years old (2.2%; 95% CI 0.9 to 4.4) (p<0.001) and to normal-weight patients (3.6%; 95% CI 2.1 to 5.6) (p<0.01), respectively. Age (OR 1.08, 95% CI 1.05 to 1.12; p<0.001), body mass index (BMI) (OR 1.10, 95% CI 1.04 to 1.16; p<0.001), and acute infection (OR 3.46, 95% CI 1.02 to 10.8; p=0.038) were predictors for DM. Comparing patients with a BMI of 20 kg/m2 and a BMI of 35 kg/m2, the relative risk for DM increases in average by 2.12-fold (range 1.91-2.24) across the age groups. Comparing patients 20 years old with patients 70 years old, the relative risk for DM increases in average 9.7-fold (range 8.9-10.4) across the BMI groups. Overall, 333 patients (36%) suffered from anemia. Pearson's correlation coefficients (r) between HbA1c and hemoglobin was -0.009 (p=0.779), and between HbA1c and fasting blood glucose and random blood glucose, it was 0.775 and 0.622, respectively (p<0.001).

CONCLUSION: We observed a high prevalence of DM and pre-DM, mainly triggered by increasing age and BMI, and provide evidence that HbA1c is suitable to assess DM also in populations of SSA with high proportions of anemia.

TRIAL REGISTRATION NUMBER: NCT03458338.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:8

Enthalten in:

BMJ open diabetes research & care - 8(2020), 1 vom: 21. Mai

Sprache:

Englisch

Beteiligte Personen:

Hodel, Nikolai Carl [VerfasserIn]
Hamad, Ali [VerfasserIn]
Reither, Klaus [VerfasserIn]
Mwangoka, Grace [VerfasserIn]
Kasella, Irene [VerfasserIn]
Praehauser, Claudia [VerfasserIn]
Abdulla, Salim [VerfasserIn]
Hatz, Christoph F R [VerfasserIn]
Mayr, Michael [VerfasserIn]

Links:

Volltext

Themen:

Age
Anemia
Body mass index
Diabetes
Epidemiology
Glycated Hemoglobin A
HbA1c
Journal Article
Pre-diabetes
Research Support, Non-U.S. Gov't
Risk factors
Sub-Sahara Africa
Tanzania

Anmerkungen:

Date Completed 21.06.2021

Date Revised 07.12.2022

published: Print

ClinicalTrials.gov: NCT03458338

Citation Status MEDLINE

doi:

10.1136/bmjdrc-2019-000939

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM310219922